mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Formation and extinction of aversive memories in the mammalian brain are insufficiently understood at the cellular and molecular levels. Using the novel metabotropic glutamate receptor 7 (mGluR7) agonist AMN082, we demonstrate that mGluR7 activation facilitates the extinction of aversive memories in two different amygdala-dependent tasks. Conversely, mGluR7 knockdown using short interfering RNA attenuated the extinction of learned aversion. mGluR7 activation also blocked the acquisition of Pavlovian fear learning and its electrophysiological correlate long-term potentiation in the amygdala. The finding that mGluR7 critically regulates extinction, in addition to acquisition of aversive memories, demonstrates that this receptor may be relevant for the manifestation and treatment of anxiety disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The gut microbiota can affect brain function by modulating serotoninergic, noradrenergic, dopaminergic, glutamatergic, and GABA-ergic neurotransmission [25,26].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [25]
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,437
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
Phelps, E. A., & LeDoux, J. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.025 · Cited by 3,203
PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
Conn, P. J., & Pin, J.-P. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,081
Paulus, M. P., & Stein, M. B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.042 · Cited by 1,325
Fear conditioning induces associative long-term potentiation in the amygdala
Rogan, M. T., Stäubli, U. V., & LeDoux, J. E. (1997) · Nature · doi:10.1038/37601 · Cited by 1,310
Myers, K. M., & Davis, M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001939 · Cited by 1,277
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Self-citationThe neuroanatomical and neurochemical basis of conditioned fear
Fendt, M., & Fanselow, M. S. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00016-0 · Cited by 1,092
Self-citationRessler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
A family of metabotropic glutamate receptors
Tanabe, Y., Masu, M., Ishii, T., Shigemoto, R., & Nakanishi, S. (1992) · Neuron · doi:10.1016/0896-6273(92)90118-w · Cited by 940
Research works printed but not linked: 1
- Davis M . The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol Sci 1992; 13: 35–41. · DOI · Paper page
Cited by
Pape, H.-C., & Pare, D. (2010) · Physiological Reviews · doi:10.1152/physrev.00037.2009 · Cited by 994
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Elia, J., Gai, X., Xie, H. M., Perin, J. C., Geiger, E., Glessner, J. T., D'arcy, M., deBerardinis, R., Frackelton, E., Kim, C., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.57 · Cited by 529
Gut microbiome and depression: what we know and what we need to know
Winter, G., Hart, R. A., Charlesworth, R. P. G., & Sharpley, C. F. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0072 · Cited by 394
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“…(Sepulveda-Orengo et al., 2013) mGluR7 KO −4 ns ns No drug (Callaerts-Vegh et al., 2006); (Goddyn et al., 2008) + + ns No drug (Fendt et al., 2013) siRNA knock-down of mGluR7 −2 ns ns No drug (Fendt et al., 2008) mGluR8 KO No effect# No effect ns No drug (Fendt et al., 2013) (S)-3,4-DCPG (mGluR8…”
BackgroundInfluentialThe age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 316
Self-citationHefner, K., Whittle, N., Juhasz, J., Norcross, M., Karlsson, R.-M., Saksida, L. M., Bussey, T. J., Singewald, N., & Holmes, A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4904-07.2008 · Cited by 248
mGluR5 Has a Critical Role in Inhibitory Learning
Xu, J., Zhu, Y., Contractor, A., & Heinemann, S. F. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5716-08.2009 · Cited by 221
New perspectives in glutamate and anxiety
Riaza Bermudo-Soriano, C., Perez-Rodriguez, M. M., Vaquero-Lorenzo, C., & Baca-Garcia, E. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.010 · Cited by 207
Urwyler, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.109.002501 · Cited by 207
Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
Krystal, J. H., Mathew, S. J., DʼSouza, D. C., Garakani, A., Gunduz-Bruce, H., & Charney, D. S. (2010) · CNS Drugs · doi:10.2165/11533230-000000000-00000 · Cited by 180
Glutamate Receptors in Extinction and Extinction-Based Therapies for Psychiatric Illness
Myers, K. M., Carlezon, W. A., & Davis, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.88 · Cited by 173
Activation of the mGlu7 receptor elicits antidepressant-like effects in mice
Pałucha-Poniewiera, A., Kłak, K., Brański, P., van der Putten, H., Flor, P. J., & Pilc, A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0856-2 · Cited by 152
Self-citationO’Connor, R. M., Dinan, T. G., & Cryan, J. F. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.162 · Cited by 146
Self-citationA genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB
Need, A. C., Attix, D. K., McEvoy, J. M., Cirulli, E. T., Linney, K. L., Hunt, P., Ge, D., Heinzen, E. L., Maia, J. M., Shianna, K. V., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp413 · Cited by 133
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: Where do we stand?
Whittle, N., & Singewald, N. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130233 · Cited by 117
Metabotropic glutamate receptor 7: At the interface of cognition and emotion
O’Connor, R. M., Finger, B. C., Flor, P. J., & Cryan, J. F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.059 · Cited by 103
Self-citationHoyer, D., & Bartfai, T. (2012) · Chemistry & Biodiversity · doi:10.1002/cbdv.201200288 · Cited by 102
Self-citationRegulation of N-Methyl-d-aspartic Acid (NMDA) Receptors by Metabotropic Glutamate Receptor 7*
Gu, Z., Liu, W., Jing, W., & Yan, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.325175 · Cited by 98
Harvey, B. H., & Shahid, M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.014 · Cited by 97
Memory for Fear Extinction Requires mGluR5-Mediated Activation of Infralimbic Neurons
Fontanez-Nuin, D. E., Santini, E., Quirk, G. J., & Porter, J. T. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhq147 · Cited by 96
Park, S., Jung, S.-W., Kim, B.-N., Cho, S.-C., Shin, M.-S., Kim, J.-W., Yoo, H. J., Cho, D.-Y., Chung, U.-S., Son, J.-W., et al. (2013) · Behavioral and Brain Functions · doi:10.1186/1744-9081-9-1 · Cited by 91
Orthosteric versus allosteric GPCR activation: The great challenge of group-III mGluRs
Flor, P. J., & Acher, F. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.013 · Cited by 91
Self-citationGee, C. E., Peterlik, D., Neuhäuser, C., Bouhelal, R., Kaupmann, K., Laue, G., Uschold‐Schmidt, N., Feuerbach, D., Zimmermann, K., Ofner, S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.542654 · Cited by 90
Self-citationWhittle, N., Hauschild, M., Lubec, G., Holmes, A., & Singewald, N. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0849-10.2010 · Cited by 81
Metabotropic glutamatergic receptors and their ligands in drug addiction
Pomierny-Chamioło, L., Rup, K., Pomierny, B., Niedzielska, E., Kalivas, P. W., & Filip, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.012 · Cited by 80
Palazzo, E., Romano, R., Luongo, L., Boccella, S., Gregorio, D. D., Giordano, M. E., Rossi, F., Marabese, I., Scafuro, M. A., de Novellis, V., et al. (2015) · Pain · doi:10.1097/j.pain.0000000000000150 · Cited by 80
Click-Modified Cyclodextrins as Nonviral Vectors for Neuronal siRNA Delivery
O’Mahony, A., Godinho, B. M. D. C., Ogier, J. R., Devocelle, M. C., Darcy, R., Cryan, J. F., & O’Driscoll, C. M. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000372 · Cited by 78
Self-citationWhittle, N., Schmuckermair, C., Gunduz Cinar, O., Hauschild, M., Ferraguti, F., Holmes, A., & Singewald, N. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.001 · Cited by 76
Fujita, Y., Morinobu, S., Takei, S., Fuchikami, M., Matsumoto, T., Yamamoto, S., & Yamawaki, S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.01.026 · Cited by 74
Deficits in acquisition and extinction of conditioned responses in mGluR7 knockout mice
Goddyn, H., Callaerts‐Vegh, Z., Stroobants, S., Dirikx, T., Vansteenwegen, D., Hermans, D., van der Putten, H., & D’Hooge, R. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.01.001 · Cited by 74
Jalan‐Sakrikar, N., Field, J. R., Klar, R., Mattmann, M. E., Gregory, K. J., Zamorano, R., Engers, D. W., Bollinger, S. R., Weaver, C. D., Days, E., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500153z · Cited by 73
Allosteric Modulation of Metabotropic Glutamate Receptors
Sheffler, D. J., Gregory, K. J., Rook, J. M., & Conn, P. J. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00010-5 · Cited by 72
Li, X., Li, J., Peng, X.-Q., Spiller, K., Gardner, E. L., & Xi, Z.-X. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.236 · Cited by 70
Fendt, M., Bürki, H., Imobersteg, S., Lingenhöhl, K., McAllister, K. H., Orain, D., Uzunov, D. P., & Chaperon, F. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1610-8 · Cited by 69
Self-citationBukalo, O., Pinard, C. R., & Holmes, A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12779 · Cited by 67
Wierońska, J. M., Stachowicz, K., Pałucha-Poniewiera, A., Acher, F., Brański, P., & Pilc, A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.08.008 · Cited by 67
Li, X., Gardner, E. L., & Xi, Z. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.11.005 · Cited by 64
Bradley, S. R., Uslaner, J. M., Flick, R., Lee, A., Groover, K. M., & Hutson, P. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.11.006 · Cited by 58
Peterlik, D., Flor, P. J., & Uschold‐Schmidt, N. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150515234920 · Cited by 58
Self-citationMetabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders
Fisher, N. M., Seto, M., Lindsley, C. W., & Niswender, C. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00387 · Cited by 58
Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications
Palazzo, E., Marabese, I., de Novellis, V., Rossi, F., & Maione, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150716165323 · Cited by 58
Bahí, A., Fizia, K., Dietz, M., Gasparini, F., & Flor, P. J. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00310.x · Cited by 57
Self-citationPałucha-Poniewiera, A., Brański, P., Lenda, T., & Pilc, A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169730 · Cited by 55
Measures of anxiety, sensorimotor function, and memory in male and female mGluR4−/− mice
Davis, M. J., Haley, T., Duvoisin, R. M., & Raber, J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.037 · Cited by 52
Julio‐Pieper, M., Hyland, N. P., Bravo, J., Dinan, T. G., & Cryan, J. F. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00713.x · Cited by 51
Self-citationRen, W., Palazzo, E., Maione, S., & Neugebauer, V. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.006 · Cited by 51
Hikichi, H., Murai, T., Okuda, S., Maehara, S., Satow, A., Ise, S., Nishino, M., Suzuki, G., Takehana, H., Hata, M., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.047 · Cited by 50
Metabotropic Glutamate Receptors: Their Therapeutic Potential in Anxiety
Spooren, W. P. J. M., Lesage, A., Lavreysen, H., Gasparini, F., & Steckler, T. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_36 · Cited by 49
Differential roles of mGlu7 and mGlu8 in amygdala-dependent behavior and physiology
Fendt, M., Imobersteg, S., Peterlik, D., Chaperon, F., Mattes, C., Wittmann, C., Olpe, H.-R., Mosbacher, J., Vranesic, I., van der Putten, H., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.052 · Cited by 47
Self-citationMetabotropic Glutamate Receptors in Central Nervous System Diseases
V. Golubeva, A., D. Moloney, R., M. O';Connor, R., G. Dinan, T., & F. Cryan, J. (2016) · Current Drug Targets · doi:10.2174/1389450116666150316224011 · Cited by 47
Self-citationToth, I., Dietz, M., Peterlik, D., Huber, S. E., Fendt, M., Neumann, I. D., Flor, P. J., & Slattery, D. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.021 · Cited by 46
Self-citationDobi, A., Sartori, S. B., Busti, D., van der Putten, H., Singewald, N., Shigemoto, R., & Ferraguti, F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.025 · Cited by 46
Genome-wide association study of personality traits in bipolar patients
Alliey-Rodriguez, N., Zhang, D., Badner, J. A., Lahey, B. B., Zhang, X., Dinwiddie, S., Romanos, B., Plenys, N., Liu, C., & Gershon, E. S. (2011) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283457a31 · Cited by 45
Bahí, A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.122 · Cited by 42
Bahí, A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.01.008 · Cited by 42
Sławińska, A., Wierońska, J. M., Stachowicz, K., Pałucha-Poniewiera, A., Uberti, M. A., Bacolod, M. A., Doller, D., & Pilc, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.001 · Cited by 42
Liu, Y., Zhang, Y., Zhao, D., Dong, R., Yang, X., Tammimies, K., Uddin, M. J., Scherer, S. W., & Gai, Z. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32306 · Cited by 41
Genetic Approaches to Modeling Anxiety in Animals
Jacobson, L. H., & Cryan, J. F. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_31 · Cited by 41
Self-citationRegulation of the brain–gut axis by group III metabotropic glutamate receptors
Julio‐Pieper, M., O’Connor, R. M., Dinan, T. G., & Cryan, J. F. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.027 · Cited by 40
Self-citationThe Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum
Boccella, S., Marabese, I., Guida, F., Luongo, L., Maione, S., & Palazzo, E. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190618121859 · Cited by 39
mGluR7 Genetics and Alcohol: Intersection Yields Clues for Addiction
Gyetvai, B. M., Simonyi, Á., Oros, M., Saito, M., Smiley, J. F., & Vadász, C. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0452-z · Cited by 39
Bashir, Y., & Khan, A. U. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1030694 · Cited by 38
Siegl, S., Flor, P. J., & Fendt, M. (2008) · NeuroReport · doi:10.1097/wnr.0b013e328307f295 · Cited by 38
Self-citationUllmer, C., Zoffmann, S., Bohrmann, B., Matile, H., Lindemann, L., Flor, P., & Malherbe, P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02090.x · Cited by 38
Self-citationAdult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse
O’Connor, R. M., Thakker, D. R., Schmutz, M., van der Putten, H., Hoyer, D., Flor, P. J., & Cryan, J. F. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.028 · Cited by 37
Self-citationRole of mGluR4 in acquisition of fear learning and memory
Davis, M. J., Iancu, O. D., Acher, F. C., Stewart, B. M., Eiwaz, M. A., Duvoisin, R. M., & Raber, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.038 · Cited by 36
Stolerman, I. P., & Price, L. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_200815 · Cited by 36
Dolan, S., Gunn, M. D., Biddlestone, L., & Nolan, A. M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832ec5d1 · Cited by 36
Masugi-Tokita, M., Flor, P. J., & Kawata, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.198 · Cited by 35
Self-citationA New Lead From Genetic Studies in Depressed Siblings: Assessing Studies of Chromosome 3
Hamilton, S. P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11060835 · Cited by 29
Li, X., Xi, Z., & Markou, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.010 · Cited by 29
Phytonutrients and their neuroprotective role in brain disorders
Adhikary, K., Ganguly, K., Sarkar, R., Abubakar, M., Banerjee, P., & Karak, P. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1607330 · Cited by 29
Role of mGlu7 receptor in morphine rewarding effects is uncovered by a novel orthosteric agonist
Hajasova, Z., Canestrelli, C., Acher, F., Noble, F., & Marie, N. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.002 · Cited by 28
TRPC Channels and Parkinson’s Disease
Sukumaran, P., Sun, Y., Schaar, A., Selvaraj, S., & Singh, B. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1088-4_8 · Cited by 25
Artigas, F., Celada, P., & Bortolozzi, A. A. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.01.005 · Cited by 23
Morawska, M. M., & Fendt, M. (2012) · Journal of Experimental Biology · doi:10.1242/jeb.068213 · Cited by 21
Self-citationKim, J., An, B., Kim, J., Park, S., Park, S., Hong, I., Lee, S., Park, K., & Choi, S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.145 · Cited by 20
Moloney, R. D., Golubeva, A. V., O’Connor, R. M., Kalinichev, M., Dinan, T. G., & Cryan, J. F. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2015.04.001 · Cited by 19
Self-citationPsychedelics, entactogens and psychoplastogens for depression and related disorders
Hoyer, D. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70088 · Cited by 18
Self-citationZhang, P., Jin, W., Lyu, Z., Lyu, X., & Li, L. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111001 · Cited by 17
Cryan, J. F., Sánchez, C., Dinan, T. G., & Borsini, F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00007-2 · Cited by 17
Self-citationRole of metabotropic glutamate receptors in CNS disorders
O’Connor, R. M., & Cryan, J. F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760334.017 · Cited by 16
Self-citationKrishnan, B., Scott, M. T., Pollandt, S., Schroeder, B. W., Kurosky, A., & Shinnick‐Gallagher, P. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.12.009 · Cited by 15
Peterlik, D., Stangl, C., Bludau, A., Grabski, D., Strasser, R., Schmidt, D., Flor, P. J., & Uschold‐Schmidt, N. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.036 · Cited by 15
Self-citationO’Mahony, C. M., Bravo, J. A., Dinan, T. G., & Cryan, J. F. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.07.018 · Cited by 15
Self-citationLi, X., & Markou, A. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150529145332 · Cited by 14
Kotlinska, J. H., Łopatyńska-Mazurek, M., Gaweł, K., Gabka, P., Jenda, M., Kruk-Słomka, M., Marszałek‐Grabska, M., Danilczuk, Z., Kędzierska, E., Talarek, S., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172512 · Cited by 14
Modulation of fear memory by retrieval and extinction: a clue for memory deconsolidation
Hong, I., Kim, J., Song, B., Park, S., Lee, J., Kim, J., An, B., Lee, S., & Choi, S. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.023 · Cited by 13
Martinetz, S. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1814-9 · Cited by 12
Slattery, D. A., Neumann, I. D., Flor, P. J., & Zoicas, I. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.010 · Cited by 12
Self-citationRole of mGluR7 in Alzheimer’s disease: pathophysiological insights and therapeutic approaches
Hunjan, G., & Aran, K. R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01765-3 · Cited by 12
Kahl, E., & Fendt, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150425002017 · Cited by 11
Self-citationCazzin, C., & Ring, C. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.11.005 · Cited by 11
Fisher, N. M., Gogliotti, R. G., Vermudez, S. A. D., Stansley, B. J., Conn, P. J., & Niswender, C. M. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00414 · Cited by 11
From Gut to Brain: The Impact of Short-Chain Fatty Acids on Brain Cancer
Saadh, M. J., Allela, O. Q. B., Kareem, R. A., Sanghvi, G. V., Menon, S. V., Sharma, P., Tomar, B. S., Sharma, A., Sameer, H. N., Hamad, A. K., et al. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08830-8 · Cited by 10
Fatimi, H. E., El‐Mansoury, B., Tinakoua, A., Ndayambaje, M., Zaid, Y., Khalki, H., & Khalki, L. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00759-w · Cited by 10
Shaban, H., O’Connor, R., Ovsepian, S. V., Dinan, T. G., Cryan, J. F., & Schellekens, H. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.003 · Cited by 10
Self-citationO’Connor, R. M., McCafferty, C. P., Bravo, J. A., Singewald, N., Holmes, A., & Cryan, J. F. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5031-4 · Cited by 10
Self-citationKaczorowska, K., Stankiewicz, A., Bugno, R., Paluchowska, M. H., Burnat, G., Brański, P., Cieślik, P., Wierońska, J. M., Milik, M., Nowak, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031981 · Cited by 10
Metadata
- Authors
- Fendt, M., Schmid, S., Thakker, D. R., Jacobson, L. H., Yamamoto, R., Mitsukawa, K., Maier, R., Natt, F., Hüsken, D., Kelly, P. H., McAllister, K. H., Hoyer, D., van der Putten, H., Cryan, J. F., & Flor, P. J.
- Affiliations
- Novartis (Switzerland) (CH)
- University of Tübingen (DE)
- Corresponding author
- Cryan, J F
- Flor, P J
- Venue
- Molecular Psychiatry
- Published
- 2007-08-21
- Volume
- 13
- Issue
- 10
- Pages
- 970-979
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2014376853
- Cited by
- 135
- References
- 57
- Citations by year
- 2025: 8 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 7 · 2017: 4 · 2016: 5 · 2015: 11 · 2014: 6 · 2013: 8 · 2012: 17
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- mGluR7, amygdala, long-term potentiation, fear conditioning, anxiety disorders, AMN082, fear memory
- MeSH terms
- Amygdala, Animals, Avoidance Learning, Benzhydryl Compounds, Cricetulus, Dose-Response Relationship, Drug, Electric Stimulation, Extinction, Psychological, Cricetinae, Humans, Male, Membrane Potentials, Memory, Neuronal Plasticity, Protein Binding, Transfection, Guanosine 5'-O-(3-Thiotriphosphate), CHO Cells, Rats, Sprague-Dawley, Receptors, Metabotropic Glutamate, Patch-Clamp Techniques, Glutamic Acid, RNA, Small Interfering, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.